Holen Sie sich die Stockscreener-App
5.37
3.24%
-0.18
Handel nachbörslich:
5.25
-0.12
-2.23%
Schlusskurs vom Vortag:
$5.55
Offen:
$5.545
24-Stunden-Volumen:
2.56M
Relative Volume:
0.51
Marktkapitalisierung:
$1.60B
Einnahmen:
$38.03M
Nettoeinkommen (Verlust:
$-146.40M
KGV:
-10.33
EPS:
-0.52
Netto-Cashflow:
$-121.38M
1W Leistung:
-6.93%
1M Leistung:
-8.98%
6M Leistung:
+122.82%
1J Leistung:
+96.70%
1-Tages-Spanne:
$5.21
$5.60
1-Wochen-Bereich:
$5.21
$5.79
52-Wochen-Spanne:
$1.8906
$6.515
Abcellera Biologics Inc Stock (ABCL) Company Profile
Firmenname
Abcellera Biologics Inc
Sektor
Branche
Telefon
(604) 559-9005
Adresse
150 W 4TH AVENUE, VANCOUVER
Vergleichen Sie ABCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
5.37 | 1.66B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-20 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-02-22 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-10-13 | Fortgesetzt | Piper Sandler | Overweight |
| 2023-02-28 | Eingeleitet | Cowen | Outperform |
| 2022-12-15 | Eingeleitet | Goldman | Buy |
| 2022-11-16 | Eingeleitet | Truist | Buy |
| 2021-12-21 | Eingeleitet | The Benchmark Company | Buy |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-01-05 | Eingeleitet | Berenberg | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-05 | Eingeleitet | SVB Leerink | Outperform |
| 2021-01-05 | Eingeleitet | Stifel | Buy |
Alle ansehen
Abcellera Biologics Inc Aktie (ABCL) Neueste Nachrichten
What makes AbCellera Biologics Inc. (8QQ) stock appealing to growth investorsWeekly Risk Summary & Daily Technical Forecast Reports - newser.com
Will AbCellera Biologics Inc. stock recover faster than peersQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Will AbCellera Biologics Inc. see short term momentum2025 Fundamental Recap & Weekly High Return Forecasts - newser.com
Understanding AbCellera Biologics Inc.’s price movementMarket Volume Summary & Real-Time Volume Surge Alerts - newser.com
Risk adjusted return profile for AbCellera Biologics Inc. analyzed2025 Price Targets & Breakout Confirmation Trade Signals - newser.com
Can AbCellera Biologics Inc. (8QQ) stock resist broad market declinesWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com
How to interpret RSI for AbCellera Biologics Inc. stock2025 Market Overview & Verified High Yield Trade Plans - newser.com
Will AbCellera Biologics Inc. stock maintain momentum in 2025July 2025 Highlights & Real-Time Volume Analysis - newser.com
Can volume confirm reversal in AbCellera Biologics Inc.Portfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
Is AbCellera Biologics Inc. (8QQ) stock dividend growth reliableMarket Activity Summary & Fast Moving Market Watchlists - newser.com
Is a relief rally coming for AbCellera Biologics Inc. holders2025 Performance Recap & Accurate Entry and Exit Point Alerts - newser.com
Is AbCellera Biologics Inc. (8QQ) stock in buy zone after pullbackJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
What earnings revisions data tells us about AbCellera Biologics Inc.2025 Top Gainers & Consistent Profit Alerts - newser.com
Real time breakdown of AbCellera Biologics Inc. stock performanceEarnings Overview Summary & Step-by-Step Swing Trade Plans - newser.com
What to do if you’re stuck in AbCellera Biologics Inc.July 2025 Price Swings & Consistent Growth Equity Picks - newser.com
What’s next for AbCellera Biologics Inc. stock price2025 Fundamental Recap & AI Driven Stock Reports - newser.com
What dividend safety rating applies to AbCellera Biologics Inc. (8QQ) stock2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com
Will AbCellera Biologics Inc. (8QQ) stock hit Wall Street targetsWeekly Profit Recap & Capital Efficiency Focused Ideas - newser.com
AbCellera Biologics Inc. stock volume spike explained2025 Big Picture & Free AI Powered Buy and Sell Recommendations - newser.com
Is AbCellera Biologics Inc. a candidate for recovery playMarket Trend Report & Weekly Top Stock Performers List - newser.com
Is it time to cut losses on AbCellera Biologics Inc.Analyst Upgrade & Smart Allocation Stock Tips - newser.com
Using flow based indicators on AbCellera Biologics Inc.Rate Hike & Daily Growth Stock Investment Tips - newser.com
AbCellera Biologics (ABCL) to Release Quarterly Earnings on Thursday - MarketBeat
How AbCellera Biologics Inc. stock reacts to Fed rate cutsWatch List & Fast Moving Stock Trade Plans - newser.com
Finanzdaten der Abcellera Biologics Inc-Aktie (ABCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):